Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (13169)	9/28/2004 2:52:57 PM
From: scaram(o)uche	Respond to of 52153

The sector has been flooded with cash for over two years, and it's still rolling in. It has delivered consistent earnings' growth while most other industries were suffering, post-9/11 crash. Pharma pipes are empty, and the population is aging. Those who establish short positions against good medicines will get crushed. Those who establish short positions and find themselves pinched by luck? They'll get swamped as well. Big-science biotechs with leverage and a decent business plan..... put together a basket, and flip the shorts off. You will do better than them.